Danaher (DHR) Signs Deal to Acquire Analytical Technologies Division of Midas, Inc (MDS)

Danaher Corporation (NYSE: DHR) has signed agreement with MDS Inc. (USA) (PNYSE: MDZ) to acquire the Analytical Technologies division of Midas, Inc.(NYSE: MDS). The deal includes a 50% ownership position in Applied Biosystems/MDS Sciex joint venture, a mass spectrometry business, and a 100% ownership position in the former Molecular Devices Corporation, a bioresearch and analytical instrumentation company.